PsyLabs - Licensed Pharmaceutical grade psychedelics supply

International Supplier of
Pharmaceutical Grade Psychoactive Compounds

PsyLabs operates legal natural psychedelic cultivation and extraction facilities based in Southern Africa. From here, PsyLabs exports raw materials and extracts to its research partners, customers and our Contract Development & Manufacturing Organisation (CDMO) partner in the UK. These will then be developed using our proprietary extraction methodology into standardized pharmaceutical grade psychedelic drug substances and Active Pharmaceutical Ingredients (API’s) with the associated supporting dossiers and regulatory support , which can then be further formulated into final products and dosage forms for regulatory approval.

These activities are in line with PsyLabs’ strategy to develop global partnerships for the supply of our pharmaceutical grade psychedelic products for research, clinical trials and drug development.

About Us

MindHealth Cultivation
and
Production Facility

A fully licensed and operational commercial Psychedelic cultivation, extraction and production facility producing quality assured psychedelic substances.

Active Pharmaceutical
Ingredient &
Intellectual Property

Our proprietary extraction and refinement process is in development to be able to produce purified API’s with associated Drug Master Files and Technical documents and will be Investigative New Drug (IND) ready. Our initial patent has already been filed in order to protect this methodology with more IP in the pipeline.

PsyLabs
Functional Products
(GoodMind)

Our range of functional mushroom wellness products harness the power of adaptogens – non-toxic, non-psychoactive fungi used in ancient medicine for their stress relieving and general wellness benefits.

PsyLabs
Laboratory

PsyLabs
Production Facility

Facility

We operate licensed ISO22000-certified psilocybin cultivation and production facilities.

PsyLabs is federally licensed to cultivate and export psilocybin mushrooms and other psychedelic compounds, including psilocin, Mescaline, Ibogaine and Dimethyltryptamine (DMT) to the legal medical and research markets. We have completed successful exports of psilocybin containing mushrooms to Canada, The United Kingdom, Portugal, Slovenia and have sent Psilocybin Extracts to our CMO partner in England.

Our facility is ISO22000 certified and audited by the British Standards Institution

For information on the supply our existing products and Active Pharmaceutical Ingredient development, please Contact Us

Our Partners

We are Regulator Ready

Our products come with a full suite of regulatory support including export permits, Certificates of Analysis and Quality Assurance. Our team are experienced in engaging with all major regulators and our sister company, Psyence Biomed has had their psilocybin-assisted psychotherapy trial approved by both the Medicines & Healthcare products Regulatory Agency in the UK and the Human Research Ethics Committee (HREC) in Australia.